EXHIBIT 10.36 AMENDMENT NO. 2 AND SUPPLEMENT TO RESEARCH COLLABORATION AND LICENSE AGREEMENTCollaboration and License Agreement • March 21st, 1997 • Synaptic Pharmaceutical Corp • Services-commercial physical & biological research
EXHIBIT 10.35 ADDENDUM NO. 2 TO RESEARCH, OPTION AND LICENSE AGREEMENTOption and License Agreement • March 21st, 1997 • Synaptic Pharmaceutical Corp • Services-commercial physical & biological research
EXHIBIT 10.37 NONTRANSFERABLE INCENTIVE STOCK OPTION AGREEMENT THIS AGREEMENT, dated as of the 13th day of December, 1996, is by and between SYNAPTIC PHARMACEUTICAL CORPORATION, a Delaware corporation (the "Company"), and Kathleen P. Mullinix (the...Nontransferable Incentive Stock Option Agreement • March 21st, 1997 • Synaptic Pharmaceutical Corp • Services-commercial physical & biological research • New Jersey
